Constipation (women) - prucalopride: final appraisal determination
After considering the feedback from consultation, the Appraisal Committee has prepared a Final Appraisal Determination (FAD) on Prucalopride for the treatment of chronic constipation in women and submitted it to the Institute.
The FAD has been sent to the formal consultees for this appraisal who have 15 working days to consider whether they wish to appeal against it. Subject to any appeal by consultees, the FAD may be used as the basis for the Institute's guidance on the use of the appraised technology in the NHS in England and Wales.
Please note that the appeal period for this appraisal will close at 5pm on 5 November 2010.
Constipation (women) - prucalopride: final appraisal determination
Constipation (women) - prucalopride: response to consultee, commentator and public comments on the ACD and comments from website consultation
Constipation (women) - prucalopride: consultee and commentator comments on the ACD
Constipation (women) - prucalopride: comments on the ACD received from the public through the NICE website
This page was last updated: 22 October 2010